245 related articles for article (PubMed ID: 25202116)
1. Predisposing factors for larynx preservation strategies with non-surgical multimodality treatment for locally advanced (T3-4) larynx, hypopharynx and cervical esophageal disease.
Suzuki G; Yamazaki H; Ogo E; Abe T; Eto H; Muraki K; Hattori C; Umeno H; Tanaka N; Tanaka T; Nakamura S; Yoshida K
Anticancer Res; 2014 Sep; 34(9):5205-10. PubMed ID: 25202116
[TBL] [Abstract][Full Text] [Related]
2. Non-surgical multimodality treatment for locally advanced (T3-4) hypopharyngeal cancer: the impact of pre-treatment hemoglobin level.
Suzuki G; Ogo E; Abe T; Hayabuchi N; Umeno H; Nakashima T; Yamazaki H; Nakamura S; Yoshida K
Anticancer Res; 2013 Dec; 33(12):5561-5. PubMed ID: 24324098
[TBL] [Abstract][Full Text] [Related]
3. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients.
Altundag O; Gullu I; Altundag K; Yalcin S; Ozyar E; Cengiz M; Akyol F; Yucel T; Hosal S; Sozeri B
Head Neck; 2005 Jan; 27(1):15-21. PubMed ID: 15515158
[TBL] [Abstract][Full Text] [Related]
4. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
5. Laryngeal preservation in advanced piriform sinus squamous cell carcinomas using superselective intra-arterial chemoradiation therapy with three agents.
Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M
Acta Otolaryngol; 2013 Mar; 133(3):318-26. PubMed ID: 23153059
[TBL] [Abstract][Full Text] [Related]
6. Multimodal approach for cervical esophageal carcinoma: role of neoadjuvant chemotherapy.
Suzuki G; Yamazaki H; Ogo E; Abe T; Eto H; Muraki K; Hattori C; Umeno H; Nakashima T; Tanaka T; Nakamura S; Yoshida K
Anticancer Res; 2014 Apr; 34(4):1989-92. PubMed ID: 24692736
[TBL] [Abstract][Full Text] [Related]
7. Larynx preservation: what is the best non-surgical strategy?
Lagha A; Chraiet N; Labidi S; Rifi H; Ayadi M; Krimi S; Allani B; Raies H; Touati S; Boussen H; Kochbati L; Mezlini A
Crit Rev Oncol Hematol; 2013 Nov; 88(2):447-58. PubMed ID: 23755889
[TBL] [Abstract][Full Text] [Related]
8. Persistent tracheostomy after primary chemoradiation for advanced laryngeal or hypopharyngeal cancer.
Tennant PA; Cash E; Bumpous JM; Potts KL
Head Neck; 2014 Nov; 36(11):1628-33. PubMed ID: 24115178
[TBL] [Abstract][Full Text] [Related]
9. Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location.
Suzuki G; Yamazaki H; Ogo E; Abe T; Hayabuchi N; Umeno H; Nakashima T; Nakamura S; Yoshida K
Anticancer Res; 2014 Jan; 34(1):203-7. PubMed ID: 24403463
[TBL] [Abstract][Full Text] [Related]
10. Recurrence patterns after postoperative radiotherapy for squamous cell carcinoma of the pharynx and larynx.
Iizuka Y; Yoshimura M; Inokuchi H; Matsuo Y; Nakamura A; Mizowaki T; Hirano S; Kitamura M; Tateya I; Hiraoka M
Acta Otolaryngol; 2015 Jan; 135(1):96-102. PubMed ID: 25351439
[TBL] [Abstract][Full Text] [Related]
11. Radiochemotherapy versus surgery plus radio(chemo)therapy for stage T3/T4 larynx and hypopharynx cancer - results of a matched-pair analysis.
Rades D; Schroeder U; Bajrovic A; Schild SE
Eur J Cancer; 2011 Dec; 47(18):2729-34. PubMed ID: 21726998
[TBL] [Abstract][Full Text] [Related]
12. Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer.
Pfister DG; Strong E; Harrison L; Haines IE; Pfister DA; Sessions R; Spiro R; Shah J; Gerold F; McLure T
J Clin Oncol; 1991 May; 9(5):850-9. PubMed ID: 2016629
[TBL] [Abstract][Full Text] [Related]
13. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
[TBL] [Abstract][Full Text] [Related]
14. Oncological results of surgical treatment versus organ-function preservation in larynx and hypopharynx câncer.
Calvas OIJ; Ramos DM; Matos LL; Kulcsar MAV; Dedivitis RA; Brandão LG; Cernea CR
Rev Assoc Med Bras (1992); 2017 Dec; 63(12):1082-1089. PubMed ID: 29489975
[TBL] [Abstract][Full Text] [Related]
15. Sequential four-drug chemotherapy and intensity-modulated radiotherapy for larynx preservation in resectable advanced larynx and hypopharynx cancer: A pilot study.
Su X; He C; Tang T; Chen W; Li Z; Chen Y; Yang A
Am J Otolaryngol; 2017; 38(1):52-56. PubMed ID: 27825651
[TBL] [Abstract][Full Text] [Related]
16. Induction chemotherapy-based larynx preservation program for locally advanced hypopharyngeal cancer: oncologic and functional outcomes and prognostic factors.
Bozec A; Benezery K; Ettaiche M; Chamorey E; Vandersteen C; Dassonville O; Poissonnet G; Riss JC; Hannoun-Lévi JM; Chand ME; Leysalle A; Saada E; Guigay J; Sudaka A; Demard F; Santini J; Peyrade F
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3299-306. PubMed ID: 26858198
[TBL] [Abstract][Full Text] [Related]
17. Organ-preservation (chemo)radiotherapy for T4 laryngeal and hypopharyngeal cancer: is the effort worth?
Al-Mamgani A; Navran A; Walraven I; Schreuder WH; Tesselaar MET; Klop WMC
Eur Arch Otorhinolaryngol; 2019 Feb; 276(2):575-583. PubMed ID: 30564952
[TBL] [Abstract][Full Text] [Related]
18. Examination of laryngoesophageal dysfunction-free survival as an endpoint in nonsurgical treatment of squamous cell carcinomas of the larynx and hypopharynx.
Caudell JJ; Carroll WR; Spencer SA; Bonner JA
Cancer; 2011 Oct; 117(19):4447-51. PubMed ID: 21437891
[TBL] [Abstract][Full Text] [Related]
19. [Results of definitive radiotherapy for squamous cell carcinomas of the larynx patients with subglottic extension].
Lévy A; Blanchard P; Janot F; Temam S; Bourhis J; Daly-Schveitzer N; Tao Y
Cancer Radiother; 2014 Jan; 18(1):1-6. PubMed ID: 24309002
[TBL] [Abstract][Full Text] [Related]
20. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary.
Lefebvre JL; Ang KK;
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1293-303. PubMed ID: 19306746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
